Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Inflammation damages sweat ducts, causing sweat gland injury.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Different materials affect the growth of brain cells and fibroblasts, with matrigel being best for brain cell growth.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Type II spiral ganglion neurites avoid high concentrations of laminin and fibronectin.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Hair glycation can indicate long-term blood sugar levels and diabetic nerve issues.

Platelet-released growth factors can reduce inflammation in joint disease.